AGEN (Agenus) Forward P/E Multiple
Agenus (AGEN) management is currently optimizing internal expenses to meet regulatory standards, while the market cautiously assesses the platform's liquidity requirements. This chart of the company's price action demonstrates the 0.00 metric, linking operational processes to market value. The business is based on the creation of anti-cancer immune drugs, utilizing exclusive patents for high-margin sales or the licensing of its developments to global behemoths.
Analytical breakdowns for Agenus
- current price and projected stock value:
- business market valuation indicators:
- book capitalization information:
- debt and liquidity details:
- company profitability and valuation multiples indicators:
AGEN - Annual Net Income|Projected Future Earnings Agenus|AGEN - Market Cap to Earnings|Future Price to Earnings Agenus Inc|AGEN - Growth-Adjusted P/E Ratio|Enterprise Value to EBITDA Ratio Agenus, Inc.|AGEN - Operating profit EBITDA|Earnings per share for the last twelve months Agenus|AGEN - Net earnings per share for the last four quarters|Quarterly EPS earnings growth agenusbio.com|AGEN - Earnings growth in current year|Earnings growth forecast for next year Agenus
Summary company analytics:Agenus Inc.
Asset quality is determined by comparing current market value with expected returns. This metric measures the ratio of the share price to projected earnings, identifying areas of overvaluation or undervaluation. By analyzing the forward P/E ratio of the company, an investor can see the deviation of value from historical risk norms. For Agenus (AGEN), this indicator reflects market confidence in the commercial success of their unique immune drug combinations.
Competitors of Agenus (AGEN)
Projected Price to Earnings ARGX (argenx)|BNTX (BioNTech Inc.) - Future Price to Earnings Multiple|Forward P/E Multiple ABVX (abivax.com)|Market Cap to Projected Earnings ADMA Corp (ADMA)|PTGX - Future Price to Earnings|immunovant.com (IMVT) - Projected Price to Earnings|Kiniksa (KNSA) - Future Price to Earnings|Projected Price to Earnings Grifols SA|Projected Price to Earnings ADPT|Forward P/E Multiple Celldex Corp|Future Price to Earnings Aurinia Pharmaceuticals (AUPH)|biocryst.com - Price to Future Earnings Ratio|Forward P/E Multiple VERA (Vera Therapeutics)|Dianthus Therapeutics Inc (DNTH) - Projected Price to Earnings Ratio|Pharvaris Corp - Forward P/E Multiple|ABCL - Forward P/E Multiple|TRML: Forward P/E Multiple|Forward Price to Earnings Multiple precigen.com PGEN|PHAR (Pharming Group) - Forward P/E Multiple|Projected Price to Earnings Ratio Nektar Therapeutics Inc NKTR|Future Price to Earnings Upstream Bio Corp (UPB)|Zenas Corp - Price to Future Earnings Ratio|Immunome, Inc. - Projected Price to Earnings|Forward P/E Multiple gossamerbio.com GOSS|KALV - Future Price to Earnings|Market Cap to Projected Earnings Septerna, Inc. SEPN|PVLA: Forward P/E Multiple|Savara Pharma (SVRA) - Forward P/E Multiple|RIGL (Rigel Pharmaceuticals) - Forward P/E Multiple|ANAB - Forward Price to Earnings Multiple|Forward P/E Multiple ATXS|ENGN - Projected Price to Earnings Ratio|Future Price to Earnings RAPT Therapeutics, Inc. RAPT|JBIO: Price to Future Earnings Ratio|ACRS - Future Price to Earnings|Price to Expected Earnings Ratio KYTX|TLSA: Forward P/E Multiple|Cabaletta Bio Inc. - Future Price to Earnings Multiple|VTYX (Ventyx Bio) - Forward P/E Multiple|Forward P/E Multiple Theratechnologies, Inc|Future Price to Earnings Avalo Therapeutics, Inc (AVTX)|ELDN (eledon.com) - Future Price to Earnings Multiple|Future Price to Earnings Climb Bio CLYM|ZURA - Projected Price to Earnings|aTyr - Forward P/E Multiple|ADAG - Forward P/E Multiple|IMA (ikenaoncology.com) - Projected Price to Earnings|Shattuck Labs - Future Price to Earnings Multiple|EQ (Equillium Inc) - Forward P/E Multiple|Connect Pharma (CNTB) - Market Cap to Projected Earnings|Future Price to Earnings Immunic, Inc. (IMUX)|Projected Price to Earnings atarabio.com ATRA|Future Price to Earnings InflaRx IFRX|XFOR - Projected Price to Earnings|ACET: Projected Price to Earnings|CELU - Forward P/E Multiple|INmune Bio Corp (INMB) - Future Price to Earnings|Price to Future Earnings Ratio BRNS|KZR (Kezar Life Sciences) - Forward P/E Multiple|Projected Price to Earnings Ratio sabbiotherapeutics.com SABS|Forward P/E Multiple AKTX|Forward P/E Multiple enlivex.com (ENLV)|Forward P/E Multiple QTTB (Q32 Bio)|Forward Price to Earnings Multiple GeoVax Corp|Edesa Biotech, Inc. - Forward P/E Multiple|Projected Price to Earnings Ratio ibioinc.com|carismatx.com (CARM) - Future Price to Earnings|Price to Future Earnings Ratio XTLB|Projected Price to Earnings BOLT|Forward P/E Multiple HCW Biologics Inc|Future Price to Earnings Aptevo Therapeutics (APVO)|Market Cap to Projected Earnings AIM ImmunoTech, Inc.|Forward P/E Multiple ADTX (Aditxt, Inc.)|Forward P/E Multiple GRI Bio Inc GRI|XORTX - Forward P/E Multiple|Forward Price to Earnings Multiple Vyome Therapeutics (HIND)|REVB: Forward P/E Multiple|Projected Price to Earnings Ratio indaptusrx.com (INDP)|Future Price to Earnings Scinai Immunotherapeutics Ltd.|Price to Future Earnings Ratio CALI (CalciMedica Corp)|Future Price to Earnings Affimed (AFMD)|ALLK: Price to Expected Earnings Ratio|Forward P/E Multiple HOOK (HOOKIPA Pharma)|Future Price to Earnings Multiple IGMS|iTeos Therapeutics, Inc. - Forward P/E Multiple|OCEA - Forward P/E Multiple|TC BioPharm (Holdings) PLC (TCBP) - Future Price to Earnings|Third Harmonic Bio Inc - Future Price to Earnings Multiple
